Evidence map›Paper›PMID 36096078›Full record

ArticleBlood2022

Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance.

Matthew Ho, Saurabh Zanwar, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri and 20 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Advanced disease and CD8Frontiers in immunology · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 3 institutions in 1 country.

Matthew HoDepartment of Internal Medicine, Mayo Clinic, Rochester, MN.
Saurabh ZanwarDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Francis K BuadiDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.ORCID 0000-0003-3214-0203
Sikander AilawadhiDivision of Hematology, Mayo Clinic, Jacksonville, FL.
Jeremy LarsenDivision of Hematology, Mayo Clinic, Scottsdale, AZ.
Leif BergsagelDivision of Hematology, Mayo Clinic, Scottsdale, AZ.ORCID 0000-0003-1523-7388
Moritz BinderDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.ORCID 0000-0001-9014-9658
Asher Chanan-KhanDivision of Hematology, Mayo Clinic, Jacksonville, FL.ORCID 0000-0002-4702-6772
David DingliDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Angela DispenzieriDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.ORCID 0000-0001-8780-9512
Rafael FonsecaDivision of Hematology, Mayo Clinic, Jacksonville, FL.
Morie A GertzDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Wilson GonsalvesDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Ronald S GoDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Suzanne HaymanDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Prashant KapoorDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Taxiarchis KourelisDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.ORCID 0000-0001-8573-9434
Martha Q LacyDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.ORCID 0000-0003-1193-1559
Nelson LeungDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.ORCID 0000-0002-5651-1411
Yi LinDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Eli MuchtarDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.ORCID 0000-0003-2210-2174
Vivek RoyDivision of Hematology, Mayo Clinic, Jacksonville, FL.ORCID 0000-0002-5950-4620
Taimur SherDivision of Hematology, Mayo Clinic, Jacksonville, FL.
Rahma WarsameDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.ORCID 0000-0003-0240-0326
Amie FonderDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.ORCID 0000-0001-9488-8212
Miriam HobbsDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Yi L HwaDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Robert A KyleDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
S Vincent RajkumarDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Shaji KumarDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.ORCID 0000-0001-5392-9284
Mayo Clinic · USWinnMed · USMayo Clinic in Arizona · US

Funding

Project 4: Targeting Resistance to T-Cell Directed Therapy in Multiple MyelomaP50CA186781 · NCI · MAYO CLINIC ARIZONA · PI Peter Leif Bergsagel · 2015 to 2026
$25.5M
NCI NIH HHS P50 CA186781
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Monoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaParaproteinemiasHumansRisk Factors

Identifiers

PMID36096078
PMCPMC9474409
OpenAlexW4295496954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.